Question. Is the supposed share ratio formula following the restructuring set at (- 30:1)? Somewhere in this debacle there must be an advantage or reason for the BK court to allow this venture to go through. Otherwise, it's simply a loosing battle and whoever holds the liability would have no ROI for the risk. It would only prolong the inevitable of a complete loss of all shareholder value and company cash.
You are correct and many holders of CYTX, (retail/small hedge funds) that is, are finding this to be the case and have been posting on Stocktwits as such. There seems to be an ongoing theme of something coming that ...A) either points to BIG news of a critical Phase II,III finding or B) someone perhaps making a tender offer for this company. Could also be the later will come quickly if the first is announced. Having fallen to these lows only to have multiple analysts throw estimates anywhere from $3 to $7 usually catches many off guard hence the Squeeze and run up. One other thing, when Adam Feuerstein speaks harshly against a company like he attempted to do with Cytori months ago, they normally come out shining in the end. He plays it both ways and gets paid doing it. He's off the radar now on Cytori so look for some major news soon!
Major Shareholders CYTX
Held % Total
Shares Held Shares
Change % Chg from
Prior Port % Total
Assets Date of
Portfolio Star Rating
Vanguard Total Stock Mkt Idx 1,380,957 1.10 63,600 4.83 0 04/30/2015
Vanguard Extended Market Idx Inv 1,124,009 0.89 0 0 0 04/30/2015
CREF Stock R1 338,091 0.30 112,526 49.89 0 03/31/2015
iShares Russell 2000 Growth 518,284 0.31 1,110 0.21 0 05/26/2015
Fidelity Spartan® Extended Mkt Index Inv 285,340 0.25 0 0 0 03/31/2015
Schwab Small Cap Index 190,900 0.17 112,900 144.74 0.01 03/31/2015
Northern Trust Russell 2000 Index Fund - DC - Non-Lending 163,548 0.14 -3,627 -2.17 0 03/31/2015
iShares Micro-Cap 230,010 0.14 0 0 0.02 05/26/2015
iShares Russell 2000 Value 217,795 0.13 0 0 0 05/26/2015
AXA 2000 Managed Volatility K 111,670 0.10 22,870 25.75 0 03/31/2015
TIAA-CREF Small-Cap Blend Idx Inst 107,834 0.09 43,860 68.56 0.01 03/31/2015
Vanguard Instl Ttl Stk Mkt Idx InstlPls 139,519 0.11 0 0 0 04/30/2015
Fidelity Spartan® Total Market Idx Inv 69,588 0.06 0 0 0 03/31/2015
BNY Mellon EB DL Mkt Completion 69,402 0.06 0 0 0 03/31/2015
JNL/Mellon Capital Small Cap Index B 64,201 0.06 0 0 0 03/31/2015
SSgA Russell Small Cap Completeness Idx 129,461 0.13 0 0 0 12/31/2014
Northern Small Cap Index 51,491 0.05 13,758 36.46 0.01 03/31/2015
CREF Equity Index R1 47,980 0.04 0 0 0 03/31/2015
VALIC Company I Small Cap Index 41,470 0.04 0 0 0 03/31/2015
The Vanguard Russell 2000 Growth Index 50,102 0.04 0 0 0.01 04/30/2015
5/12/2015 Ascendiant Capital Markets Initiated Coverage Buy $1.25 View Rating Details Tweet This Rating Share This Rating on StockTwits
4/24/2015 Maxim Group Reiterated Rating Buy $7.00 View Rating Details Tweet This Rating Share This Rating on StockTwits
4/7/2015 Laidlaw Reiterated Rating Buy View Rating Details Tweet This Rating Share This Rating on StockTwits
3/13/2015 Roth Capital Set Price Target Buy $6.00 View Rating Details Tweet This Rating Share This Rating on StockTwits
2/19/2015 Maxim Group Set Price Target Buy $7.00 View Rating Details Tweet This Rating Share This Rating on StockTwits
2/17/2015 Roth Capital Set Price Target Buy $6.00 View Rating Details Tweet This Rating Share This Rating on StockTwits
1/16/2015 Roth Capital Boost Price Target Buy $3.50 - $6.00
Cytori Therapeutics Inc (NASDAQ:CYTX) has received a short term rating of buy from research analysts at Zacks with a rank of 2. The company has been rated an average of 1 by 2 Wall Street Analysts. 2 analysts have added the shares in their list of strong buys.
Ascendiant Capital initiates coverage on Cytori Therapeutics Inc (NASDAQ:CYTX) The current rating of the shares is Buy. Equity Analysts at the Firm announces the price target to $1.25 per share. Cytori Therapeutics Inc (NASDAQ:CYTX) shares are expected to touch $6.5 in the short term. This short term price target has been shared by 2 analysts. However, the standard deviation of short term price estimate has been valued at 0.71. The target price could hit $7 on the higher end and $6 on the lower end.
Even 1/2 value of these estimates and we'll see record volume! Holding my 34K with a death grio!
This was more than anyone could have asked for! A beat on ER and reducing debt while maintaining future contracts while oil bounces up and down. It clearly has to sink in for those in the market and may seem minuscule but this is better than investors could have expected! They have a ridiculous law suit pending against a board member that will soon add value back to the company as well as a deferred payment due them in July! Next Q will be stellar.
Correction Earnings s/b +$0.06 and still a $+$0.02 BEAT!
this will begin to walk up in an orderly and deserving fashion. That even surpasses the the high estimate of $0.05 , people will eventually catch on! no worries about BK here!
HOUSTON, TX—(MARKET WIRE)—May 7, 2015 — Vantage Drilling Company (“Vantage” or the “Company”) (NYSE MKT: VTG) reports net income for the three months ended March 31, 2015 of $21.4 million or $.06 per diluted share as compared to earnings of $24.8 million or $.07 per diluted share for the three months ended March 31, 2014
the price. However prior to that ER just 30 day earlier they hit $0.69 on news. It's forward guidance that moves VTG tomorrow and future contracts but $0.04 is already priced in. Oil is headed higher and VTG is trading sideways $0.38 - $0.42. while SDRL, HERO, PGN keep bumping up. Management needs adjusted contracts for higher profits for this to climb. They better have ammo ready in today's volatile trading market because status quo isn't being rewarded. C'mon VTG give shareholders some news with future contracts!